NOT-OD-19-012: NIH Offers Assistance to Active Phase I HHS SBIR and STTR Awardees throu... - 0 views
-
MiamiOH OARS on 09 Oct 18NIH announces the launch of the 2018-2019 Niche Assessment Program available to HHS (NIH, CDC, FDA) SBIR and STTR Phase I awardees and Phase I Fast-Track awardees (by grant or contract). The Niche Assessment program provides a third party, unbiased assessment of appropriate market niches for products/services that are being developed by HHS SBIR/STTR Phase I awardees and is carried out by Foresight Science & Technology on behalf of NIH. Using its Technology Niche Analysis® (TNA®), Foresight will perform the due diligence on markets appropriate for each SBIR technology and develop an in-depth report for each SBIR/STTR awardee that addresses: --needs and concerns of end-users --competing technologies and competing products --competitive advantage of the SBIR/STTR-developed technology --market size and potential market share (may include national and/or global markets) --barriers to market entry (may include, but is not limited to pricing, competition, government regulations, manufacturing challenges, capital requirements, etc.) --market drivers --status of market and industry trends --potential customers, licensees, investors, or other commercialization partners --price customers are likely to pay